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Three-dimensional (3D) cell culture is a powerful tool to study cell
growth under 3D condition. To perform a simple test for anti-
cancer drugs in 3D culture, visualization of non-proliferated cells is
required. We propose a ﬂuorescent imaging-based assay to analyze
cancer cell proliferation in 3D culture. We used a pulse-labeling
technique with a photoconvertible ﬂuorescent protein Kaede to
identify non-proliferated cells. This assay allows us to observe
change in cell proliferation in 3D culture by simple imaging. Using
this assay, we obtained the data of the effects of anti-cancer drugs,
5-ﬂuorouracil and PD0332991 in a breast cancer cell line, MCF-7.
& 2015 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Speciﬁcations tableubject area Biology
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acquiredValue of the data
Pulse-labeling withMicroscopeata format Analyzed
xperimental factors Breast cancer cells were cultured in three-dimensional condition.
xperimental
featuresCells were pulse-labeled with Kaede-red ﬂuorescent protein, and analyzed
whether cells were proliferated. The effects of anti-cancer drugs were
tested.ata source location Kyoto, Japan
ata accessibility Data is in this article. The detailed procedure is in the supplementary
material.ﬂuorescent protein is useful technique to analyze cell proliferation in three-
dimensional culture.
 Non-proliferated cells are easily identiﬁed by pulse-labeling in three-dimensional culture.
 Our ﬂuorescent imaging-based analysis can evaluate anti-cancer drug effects on cell proliferation.2. Data, experimental design, materials and methods
In the process of drug development, animal studies are required to evaluate candidates obtained
from two-dimensional (2D) cell culture. However, experiments with animals are costly and labor-
intensive, and should be reduced to protect animals. Therefore, a useful pre-animal study model is in
demand. Three-dimensional (3D) culture is considered to have more similar characteristics to the
in vivo environment than to 2D culture, and is a favorable technique to ﬁll the gap between 2D
cultures and animal studies.
The desired function of most anti-cancer drugs is proliferative inhibition. In 3D culture, change in
cancer growth is analyzed by observation of the size and the morphology of a colony, and it is difﬁcult
to judge whether alterations are due to changes in cell proliferation and/or survival. To overcome this
problem, simple proliferation assay is needed.
We demonstrate a ﬂuorescent imaging-based assay to analyze anti-cancer drug effects on 3D
growth. We utilized a ﬂuorescent protein Kaede for pulse-labeling. The ﬂuorescent color of Kaede can
be irreversibly changed from green to red (Kaede-red) by irradiation with short wavelength light [1].
We used a luminal breast cancer cell line, MCF-7, and performed pulse-labeling with Kaede-red for
visualization of non-proliferated cells. Cells were treated with anti-cancer drugs, and subsequent
changes in cell proliferation were analyzed.
2.1. Material and methods
A detailed procedure for the ﬂuorescent imaging-based assay is described in the supplementary
material.
Establishment and maintenance of Kaede-expressing MCF-7 cells were described previously [2].
For 3D culture, cells were suspended in 5% phenol red-free Matrigel (Corning, 356237, Bedford, MA,
USA) and plated in a Matrigel-coated well of a clear-bottom 96-well plate (BD Falcon, 353219,
Franklin Lakes, NJ, USA). Anti-cancer drugs we used were 5-ﬂuorouracil (Wako, 064-01403, Osaka,
Japan) and PD0332991 (Selleck Chemicals, S1116, Houston, TX, USA).
Fig. 1. A ﬂuorescent imaging method for analyses of cell proliferation under 3D condition. (A) Cartoon of 3D culturing and
pulse-labeling with Kaede-red. Cells were cultured on a basement membrane matrix and irradiated with short wavelength
light for photoconversion. (B) Cartoon of image acquisition and focus stacking. (C) Fluorescent imaging to detect proliferated,
and non-proliferated cells. At day 0, all cells have strong Kaede-red. At day 3, proliferated cells have weak Kaede-red signals.
Non-proliferated cells are identiﬁed as cells with strong Kaede-red signals.
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erate Kaede-red, cultures were irradiated with 340–380 nm light for 2.5 minutes. Twelve sections
were taken every 5 μm, and stacked using BZ-II software (Keyence). The size of each picture is
1.45 mm1.04 mm. Kaede-red intensity was obtained by measuring the mean value of each nucleus
using ImageJ software.
Statistical analyses were performed with Student's t-test. Po0.05 was considered statistically
signiﬁcant.2.2. Pulse-labeling with Kaede-red
Previously we established Kaede-expressing cell lines that have Kaede expression in their nuclei,
and optimized a non-toxic photoconversion condition for pulse-labeling [2]. The Kaede-expressing
cells were cultured in a 3D culture system on the basement membrane matrix (Fig. 1A). In high-
density 3D culture, signals overlap. To avoid overlapping ﬂuorescent signals, we plated small numbers
of cells (e.g. 4104 MCF-7 cells was used per well). One day after setting up the 3D culture, cells were
irradiated with 340–380 nm light to generate Kaede-red.
Fig. 2. The effect of anti-cancer drugs on 3D cell growth. (A–C) Images of MCF-7 cells treated with PBS (A), 5 μM 5-FU (B), or
50 μM 5-FU (C). Bright-ﬁeld and ﬂuorescent images are shown. (D) Graph of the ratio of non-proliferated cells in the control
and 5-FU treated groups (n¼4). (E–G) Images of MCF-7 cells treated with DMSO (E), 100 nM PD0332991 (F), or 1 μM
PD0332991 (G). Bright-ﬁeld and ﬂuorescent images are shown. (H) Graph of the ratio of non-proliferated cells in the control
and PD0332991 treated groups (n¼3). Bar indicates 100 μm. Error bars represent the standard deviation. PD: PD0332991, n.s.:
non-signiﬁcant change, *: Po0.05, **: Po0.01.
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an image via focus stacking (Fig. 1B). We took pictures on day 0 and day 3 with the same exposure
time to determine whether Kaede-red intensity was reduced at day 3.
Kaede-red molecules are generated only when a cell is exposed to short wavelength light, and the
intensity of Kaede-red ﬂuorescence per cell is reduced by cell division [2]. Therefore, proliferated cells
have weak Kaede-red ﬂuorescence after culturing, while cells that have not proliferated exhibit strong
ﬂuorescence (Fig. 1C).
2.3. Treatment with 5-ﬂuorouracil and PD0332991
Our assay enables us to analyze changes in the number of non-proliferated cells after drug
administration. To analyze the effect of a drug, we added the drug after taking pictures at day 0.
Subsequently, cells were cultured for 3 days, and pictures were taken.
We calculated the mean value of Kaede-red at day 0, which was used as a reference to analyze the
change in Kaede-red intensities of the cells in the corresponding day 3 culture. We deﬁned cells
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proliferated cells at day 3, because our previous study has shown that Kaede-red intensity is reduced
to less than 78% by cell division [2].
We ﬁrst analyzed the effect of 5-ﬂuorouracil (5-FU), a pyrimidine analog. Its main functions are the
blocking of de novo thymidine synthesis by binding to thymidylate synthase, and inhibition of RNA
processing and function by incorporation into RNA [3,4]. After 3 days of culture, we observed no
remarkable morphological changes in MCF-7 cells (Fig. 2A–C).
We analyzed the number of non-proliferated cells, and obtained a ratio of non-proliferated cells in
each culture (Fig. 2D). Approximately half of the cells were non-proliferated in the presence of 50 μM
5-FU, implying that 5-FU is an effective growth inhibitor for 3D-cultured MCF-7 cells.
A cyclin-dependent kinase (CDK) 4/6 inhibitor, PD0332991, is known to affect the growth of breast
cancer cells [5]. However, growth inhibition in 3D culture has not been well studied. We tested the
effects of PD0332991 via our ﬂuorescent imaging. The morphology of colonies was not altered by
treatment with PD0332991 (Fig. 2E–G). As PD0332991 inhibits the function of CDK4/6, we observed
an increase in the ratio of non-proliferated cells in MCF-7 cells (Fig. 2H).Acknowledgments
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